|
1
|
Victoria-Castro AM, Corona-Villalobos CP, Xu AY, Onul I, Huynh C, Chen SW, Ugwuowo U, Sarkisova N, Dighe AL, Blank KN, Blanc VM, Rose MP, Himmelfarb J, de Boer IH, Tuttle KR, Roberts GV. Participant Experience with Protocol Research Kidney Biopsies in the Kidney Precision Medicine Project. Clin J Am Soc Nephrol 2024; 19:202-212. [PMID: 37871973 PMCID: PMC10861112 DOI: 10.2215/cjn.0000000000000334] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2023] [Accepted: 10/16/2023] [Indexed: 10/25/2023]
Abstract
BACKGROUND Kidney biopsies are procedures commonly performed in clinical nephrology and are increasingly used in research. In this study, we aimed to evaluate the experiences of participants who underwent research kidney biopsies in the Kidney Precision Medicine Project (KPMP). METHODS KPMP research participants with AKI or CKD were enrolled at nine recruitment sites in the United States between September 2019 and January 2023. At 28 days postbiopsy, participants were invited to complete a survey to share their experiences, including motivation to participate in research, comprehension of informed consent, pain and anxiety during and after the biopsy procedure, overall satisfaction with KPMP participation, and effect of the study on their lives. The survey was developed in collaboration with the KPMP Community Engagement Committee and the Institute of Translational Health Sciences at the University of Washington. RESULTS One hundred and eleven participants completed the survey, 23 enrolled for AKI and 88 for CKD. The median age was 61 (interquartile range [IQR], 48-67) years, 43% were women, 28% were Black, and 18% were of Hispanic ethnicity. Survey respondents most commonly joined KPMP to help future patients (59%). The consent form was understood by 99%, and 97% recognized their important role in this study. Pain during the biopsy was reported by 50%, at a median level of 1 (IQR, 0-3) on a 0-10 scale. Anxiety during the biopsy was described by 64% at a median level of 3 (IQR, 1-5) on a 0-10 scale. More than half conveyed that KPMP participation had an effect on their diet, physical activity, and how they think about kidney disease. CONCLUSIONS KPMP survey respondents were most commonly motivated to participate in research protocol kidney biopsies by altruism, with excellent understanding of the informed consent process. PODCAST This article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast/CJASN/2023_11_20_CJN0000000000000334.mp3This article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast/CJASN/2023_11_20_Spanish_CJN00000000.mp3.
Collapse
Grants
- R01 DK121019 NIDDK NIH HHS
- U01 DK114866 NIDDK NIH HHS
- U01 DK133090 NIDDK NIH HHS
- U01 DK114933 NIDDK NIH HHS
- U01 DK114908 NIDDK NIH HHS
- U01 DK133095 NIDDK NIH HHS
- U01 DK133081 NIDDK NIH HHS
- U01 DK114907 NIDDK NIH HHS
- U01 DK114920 NIDDK NIH HHS
- U24 DK114886 NIDDK NIH HHS
- U01 DK133766 NIDDK NIH HHS
- U01 DK114923 NIDDK NIH HHS
- U01 DK133113 NIDDK NIH HHS
- U01 DK133097 NIDDK NIH HHS
- U01DK133081, U01DK133091, U01DK133092, U01DK133093, U01DK133095, U01DK133097, U01DK114866, U01DK114908, U01DK133090, U01DK133113, U01DK133766, U01DK133768, U01DK114907, U01DK114920, U01DK114923, U01DK114933, U24DK114886. NIDDK NIH HHS
- U01 DK133768 NIDDK NIH HHS
- U01 DK133092 NIDDK NIH HHS
- U01 DK133091 NIDDK NIH HHS
- U01 DK133093 NIDDK NIH HHS
Collapse
Affiliation(s)
| | | | - Alan Y. Xu
- Division of Nephrology, School of Medicine, Johns Hopkins University, Baltimore, Maryland
| | - Ingrid Onul
- Boston Medical Center, Boston, Massachusetts
| | | | - Sarah W. Chen
- Kidney and Hypertension Unit, Joslin Diabetes Center, Boston, Massachusetts
| | - Ugochukwu Ugwuowo
- Clinical and Translational Research Accelerator, Yale School of Medicine, New Haven, Connecticut
| | - Natalya Sarkisova
- Division of Nephrology, Kidney Research Institute, University of Washington, Seattle, Washington
| | - Ashveena L. Dighe
- Division of Nephrology, Kidney Research Institute, University of Washington, Seattle, Washington
| | - Kristina N. Blank
- Department of Biostatistics, University of Washington, Seattle, Washington
| | - Victoria M. Blanc
- Office of Research, University of Michigan Medical School, Ann Arbor, Michigan
| | - Michael P. Rose
- Division of Nephrology, Kidney Research Institute, University of Washington, Seattle, Washington
| | - Jonathan Himmelfarb
- Division of Nephrology, Kidney Research Institute, University of Washington, Seattle, Washington
| | - Ian H. de Boer
- Division of Nephrology, Kidney Research Institute, University of Washington, Seattle, Washington
| | - Katherine R. Tuttle
- Division of Nephrology, Kidney Research Institute, University of Washington, Seattle, Washington
| | - Glenda V. Roberts
- Division of Nephrology, Kidney Research Institute, University of Washington, Seattle, Washington
- Kidney Precision Medicine Project Patient Partner, Seattle, Washington
| |
Collapse
|